New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
10:13 EDTSNMXFDA says it has not made GRAS determination for Sweetmyx
In a post dated March 12, the FDA said it had not made a "generally recognized as safe," or GRAS, determination on the food ingredient Sweetmyx, nor had it been notified by Senomyx regarding a GRAS determination for this food ingredient. The FDA noted that on March 11 Senomyx issued a public statement suggesting that Sweetmyx was generally recognized as safe and that the statement appeared to suggest that the FDA had made the GRAS determination. The FDA said the company’s statement has been corrected and now notes that a third party organization made the determination. Reference Link
News For SNMX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
08:32 EDTSNMXSenomyx sees FY15 EPS (35c)-(28c), consensus (13c)
Sees FY15 revenue $25M-$30M, consensus $37.25M. Sees FY15 commercial revenue $7M-$10M. Sees FY15 total operating expenses of $40M-$43M. The revenues range is primarily based on anticipated milestone achievements, direct sales ramp-up, and Sweetmyx S617 commercialization. The range for expenses is primarily based on timing around potential outsourced research and development activities, the cost of commercial revenues associated with the commercial revenues guidance range and variability associated with performance-based compensation.
08:31 EDTSNMXSenomyx reports Q4 EPS (7c), consensus (11c)
Reports Q4 revenue $6.26M, consensus $6.59M

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use